Our strength is in our breadth
Signed in as:
- INTERNATIONAL PAIN SURVEY
- JOIN US
- CONTACT US
- UIC VIDEOS - SAT 21 MAY
- UIC VIDEOS - SUN 22 MAY
- DRUG DRIVING
- INFORMATION FOR PATIENTS
- USEFUL LINKS
Our strength is in our breadth
Signed in as:
The guidance provided through the link below is intended to assist stakeholders with an interest in disseminating information about medicinal cannabis to ensure they do not illegally advertise prescription medicines, including unapproved medicines only available through special access pathways, to consumers.
The guidance aims to assist providers of medicinal cannabis products and therapies (including sponsors, manufacturers, importers, pharmacists, health professionals and marketers) to comply with the therapeutic goods advertising restrictions. Criminal and civil penalties may apply if you do not comply with your legal requirements.
The focus of this guidance is to help you to understand how to promote your business and service without advertising medicinal cannabis products to the public, which is prohibited.
The guidance provides information about:
For general information on advertising therapeutic goods, see the Advertising Hub: Advertising code and guidance and Why and how the advertising of therapeutic goods is regulated.
Copy or click on this link or the button below: https://www.tga.gov.au/publication/advertising-guidance-businesses-involved-medicinal-cannabis-products
Information, Licence & Permit application forms, etc.
02 6289 4618
Licence applications: Legislation enabling the domestic cultivation, production and manufacture of cannabis for medicinal purposes commenced on 30 October 2016.
Application forms for medicinal cannabis licences, cannabis research licences and manufacture licences are now available online which can be accessed on the application forms and guidance page of the ODC website.
Please ensure you are familiar with all guidelines and guidance documents prior to commencing any application.
Should you have difficulty completing or submitting your application using the online form, please email firstname.lastname@example.org.
Import/export enquiries: Enquiries of this nature should be directed to email@example.com
For more general enquiries, please use firstname.lastname@example.org.
Further information may be found on the ODC website at www.odc.gov.au
Therapeutic goods advertising is subject to the requirements of the Therapeutic Goods Act 1989 (the Act), as administered by the Therapeutic Goods Administration (TGA). The majority of the Act's requirements apply solely to consumer based advertising. Only a small number of requirements in the Act apply to advertising directed exclusively to health professionals. This is because health professionals have the appropriate knowledge and skill to critically analyse advertisements and recognise their persuasive intent.
Exposing consumers to advertising intended for health professionals may disrupt the doctor/patient relationship and create an inappropriate demand for a good, or encourage inappropriate self-diagnosis. Therefore, it is important that consumers do not access advertising meant for health professionals. Advertisers can choose the way advertising is restricted; however, inadequate restriction may lead to advertiser non-compliance.
The information through this link https://www.tga.gov.au/advertising-health-professionals explains how to direct therapeutic goods advertising exclusively to health professionals so that the consumer advertising requirements do not apply (or click button below)
The TGA may pursue sanctions and penalties against those who do not comply with the advertising and other applicable regulatory requirements. Failing to have regard to the general principles set out on this TGA site may risk the statement or promotion being a contravention of the Therapeutic Goods Act 1989 (the Act) and the Therapeutic Goods Advertising Code (No.2) 2018 (the Code).
If you wish to make a complaint or report advertising that you believe is in breach of the TGA therapeutic goods advertising code, please click the image above or the TGA button below to submit your complaint directly to the TGA.
For general advice on regulations surrounding medicinal cannabis please see:
To see all public submissions and the final report, click "Senate Inquiry" button below
APPLIED CANNABIS RESEARCH IS A CONTRACT RESEARCH ORGANISATION FOCUSED EXCLUSIVELY ON MEDICINAL CANNABIS TREATMENTS.
Applied Cannabis Research is dedicated to assisting medicinal cannabis companies with the development of their products with a single, unified vision: the faster the clinical development stage is accomplished the quicker medicinal cannabis treatments reach those who need them – the patients.
There are a number of active clinical trials happening around Australia that are looking for patients and doctors to participate. Click the link to his site to see a list of current studies that are ongoing or about to launch in Australia. There are clinical trials of all types including observational studies, randomised-controlled trials with a placebo and also experimental studies looking at related aspects such as driving impairment.
This is a useful resource for patients interested in study participation.
Cannabis Law Report has been covering the law of cannabis and legal issues on a daily basis for the last 5 years
Launched in July 2020, Cannabiz is a media platform dedicated to the growth of Australia’s legal cannabis industry.
Cannabiz informs, educates and connects the sector through its website, weekly industry newsletter, podcasts, market intelligence, industry reports, networking events and business consulting services.
Cannabiz founders Martin Lane and Kim McKay and the Cannabiz team are dedicated to supporting Australia’s growth in the global legal cannabis market.
A team of educators and advocates from the Cannabis Law Reform Alliance have joined forces to be the voice for cannabis law reform Australia-wide. The CLRA’s first campaign is Drive Change.
"Patients who are are legally prescribed and properly using these medications are not impaired, yet they cannot drive, it’s absurd. THC of course can cause impairment, but it can also be used in small amounts effectively without impairment. The current driving law is a major barrier preventing many doctors from incorporating medical cannabis into their practice and has nothing to do with impairment, randomly testing medical cannabis patients just confirms they are taking their medications." Dr David Gunn MD
Click here for an easy 3 minute read on medicinal cannabis
The Honahlee site offers a "Find a cannabis Nurse Practitioner, Specialist or GP prescriber".
To find a cannabis prescriber near you, click to reach the Honahlee site
The Lambert Initiative was created when Barry and Joy Lambert made a $33.7 million donation for research into the therapeutic use of medicinal cannabis. Click below for more information:
One year ago today, on 8 July 2021, the Governor-General, His Excellency General the Honourable David Hurley AC DSC (Retd), issued Letters Patent, which established the Royal Commission into Defence and Veteran Suicide. Since then the Royal Commission has made substantial inroads in progressing our inquiries into Defence and veteran suicide.
In the past year the Royal Commission has received over 1,700 submission, held 137 private sessions, and had almost 2,000 phone enquiries. We have conducted public hearings in Brisbane, Sydney, Canberra and Townsville, with 179 witnesses at those hearings and 63,703 livestream views. cannabis market.